Programmable Morphology-Adaptive Peptide Nanoassembly for Enhanced Catalytic Therapy.

Area of Science:

• Biomaterials Science
• Nanotechnology
• Cancer Therapeutics

Background:

• Nanocatalytic therapy shows promise for cancer treatment by leveraging tumor cell oxidative stress.
• Efficient delivery and in situ catalytic activity of nanocatalytic agents are key challenges.
• Morphology-adaptive systems offer spatiotemporal control in complex biological environments like the tumor microenvironment.

Purpose of the Study:

• To introduce FeFKC, an innovative adaptive material for multi-step morphological transformations.
• To demonstrate programmable shape-shifting for enhanced nanocatalytic tumor therapy.
• To overcome biological barriers and improve catalytic efficiency in cancer treatment.

Main Methods:

• FeFKC material design for multi-step morphological transformations.
• Investigating pH-responsive shape changes (single chains, nanoparticles, nanofibers).
• In vivo studies to evaluate tumor penetration, cellular uptake, lysosomal escape, and therapeutic efficacy.

Main Results:

• FeFKC exhibits dynamic shape transitions in response to decreasing pH.
• Programmable shape-shifting enhances tumor penetration, cellular uptake, and lysosomal escape.
• In vivo studies show up to 95% tumor suppression with no significant biosafety concerns.

Conclusions:

• Adaptive nanomaterials with programmable shape-transforming capabilities can overcome biological barriers.
• FeFKC significantly enhances nanocatalytic tumor therapy efficacy.
• This approach opens new avenues for cancer treatment and other complex diseases.